BIA Assessment of Polymyoneuropathy in Critically Ill Patients
Bioelectric Impedance Analysis (BIA) Assessment of Polymyoneuropathy in Critically Ill Patients as a Part of Post-ICU Syndrome
1 other identifier
interventional
60
1 country
2
Brief Summary
The aim of the study is to monitor and evaluate changes in body composition, with a special emphasis on muscle mass, in the context of polyneuromyopathy of critically-ill patients at ICU, on artificial ventilation (duration of artificial ventilation at least 7 days), and subsequent comparison with the patient's condition in 12 weeks, as a part of Post-Intensive Care Syndrome (PICS) monitoring. The effect of the package (nutritional recommendations + physiotherapy protocol vs. standard of care) will be evaluated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable sepsis
Started Mar 2021
Longer than P75 for not_applicable sepsis
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 14, 2021
CompletedFirst Posted
Study publicly available on registry
February 17, 2021
CompletedStudy Start
First participant enrolled
March 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 29, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2024
CompletedJanuary 18, 2024
January 1, 2024
3 years
January 14, 2021
January 17, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Body composition
Body composition will be studied using bioimpedance analysis - comparison of skeletal muscle mass, fats, body fluids
12 weeks
Secondary Outcomes (5)
Changes in the albumin level
12 weeks
Changes in the prealbumin level
12 weeks
Changes in the C-reactive protein (CRP) level
12 weeks
Changes in the presepsin level
12 weeks
Comparison of muscle functions
12 weeks
Other Outcomes (4)
Functional limitations - time up and go test (TUG)
12 weeks
Functional limitations - spirometry - forced vital capacity (FCV)
12 weeks
Functional limitations - spirometry - forced expiratory velocity (FEV1)
12 weeks
- +1 more other outcomes
Study Arms (2)
Nutritional and physiotherapy protocol, BIA
EXPERIMENTALStudy subjects randomized into this study arm will be indicated for nutritional and physiotherapy protocol, based upon the obtained results of the measurements, using bioimpedance analysis.
Standard of care
ACTIVE COMPARATORStudy subjects randomized into this study arm will be provided the current standard of care.
Interventions
Study subjects will be treated using the nutritional and physiotherapy protocol, based upon the results of measurements, using bioimpedance analysis.
Eligibility Criteria
You may qualify if:
- Patients with respiratory insufficiency
- Expected period of artificial ventilation of 7 days
- Acute lung injury (ALI)
- Acute respiratory distress syndrome (ARDS)
- Acute exacerbation of chronic obstructive pulmonary disease (COPD)
- Signed informed consent (may be signed by witnesses, if the patient is unconscious)
You may not qualify if:
- Patients with unfavorable prognosis for 12-week follow-up
- APACHE Score \>30
- Metastasizing malignity
- Patients after cardiopulmonary resuscitation (CPR) prior to admission
- Cerebral edema
- Cerebral trauma
- Intracranial hypertension
- Liver cirrhosis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital Ostravalead
- University of Ostravacollaborator
Study Sites (2)
University of Ostrava, Department of Physiology and Patophysiology
Ostrava, Moravian-Silesian Region, 70300, Czechia
University Hospital Ostrava
Ostrava, Moravian-Silesian Region, 70852, Czechia
Related Publications (1)
Kanova M, Petrekova K, Borzenko N, Ruskova K, Nytra I, Dzurnakova P, Burda M, Konvicka J. Bioelectrical Impedance in Monitoring Hyperhydration and Muscle Wasting in Critically Ill Corona Virus Disease (COVID-19) Patients: The Feasibility of Predicting Outcome. Physiol Res. 2025 Dec 31;74(Suppl 1):S93-S106.
PMID: 41511101DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marcela Káňová, MD, Ph.D.
University Hospital Ostrava
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- No masking is used in the study
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 14, 2021
First Posted
February 17, 2021
Study Start
March 1, 2021
Primary Completion
February 29, 2024
Study Completion
May 31, 2024
Last Updated
January 18, 2024
Record last verified: 2024-01
Data Sharing
- IPD Sharing
- Will not share
There is no plan to make individual participant data available to other researchers.